JEFFS ROGER
Insider CIK 1231615 · SGMO Director · UTHR President & Co-CEO, Director · ALBO Director · AXSM Director · AXON Director · DOVA Director · LQDA Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LQDA Liquidia Corp | S Sale | 2026-10-12 | 2026-10-13 | 32,744 | $28.48 | $932.5K | 1,125,848 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-10-09 | 2026-10-13 | 14,333 | — | $0 | 128,996 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-10-09 | 2026-10-13 | 13,833 | — | $0 | 69,168 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-10-09 | 2026-10-13 | 14,333 | — | — | 1,158,592 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-10-09 | 2026-10-13 | 13,833 | — | — | 1,144,259 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-07-13 | 2026-07-14 | 2,505 | $71.39 | $178.8K | 1,163,170 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-07-13 | 2026-07-14 | 32,744 | $71.52 | $2.34M | 1,130,426 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-07-10 | 2026-07-14 | 13,834 | — | $0 | 83,001 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-07-10 | 2026-07-14 | 14,333 | — | $0 | 143,329 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-07-10 | 2026-07-14 | 13,834 | — | $0 | 1,151,342 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-07-10 | 2026-07-14 | 14,333 | — | $0 | 1,165,675 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-11 | 2026-06-11 | 286 | $249.12 | $71.2K | 58,367 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2026-06-10 | 2026-06-11 | 286 | $246.18 | $70.4K | 58,653 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-06-08 | 2026-06-10 | 1,429 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-06-08 | 2026-06-10 | 1,429 | — | $0 | 58,939 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-06-05 | 2026-06-09 | 1,721 | — | $0 | 1,721 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-27 | 2026-05-28 | 6,428 | $62.18 | $399.7K | 1,041,667 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-26 | 2026-05-26 | 25,000 | $60.38 | $1.51M | 1,048,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-22 | 2026-05-26 | 25,000 | $61.52 | $1.54M | 1,073,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-21 | 2026-05-26 | 25,000 | $61.13 | $1.53M | 1,098,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-20 | 2026-05-20 | 25,000 | $61.30 | $1.53M | 1,123,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-19 | 2026-05-20 | 25,000 | $58.65 | $1.47M | 1,148,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-18 | 2026-05-20 | 25,000 | $56.77 | $1.42M | 1,173,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-15 | 2026-05-15 | 25,000 | $57.04 | $1.43M | 1,198,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-14 | 2026-05-15 | 25,000 | $58.62 | $1.47M | 1,223,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-13 | 2026-05-15 | 25,000 | $56.29 | $1.41M | 1,248,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-12 | 2026-05-12 | 25,000 | $54.04 | $1.35M | 1,273,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-11 | 2026-05-12 | 25,000 | $41.50 | $1.04M | 1,298,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-08 | 2026-05-12 | 25,000 | $42.14 | $1.05M | 1,323,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-07 | 2026-05-07 | 25,000 | $42.09 | $1.05M | 1,348,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-06 | 2026-05-07 | 25,000 | $40.78 | $1.02M | 1,373,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-05-05 | 2026-05-07 | 25,000 | $40.10 | $1.00M | 1,398,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-17 | 2026-04-21 | 18,839 | $40.60 | $764.9K | 1,423,095 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-16 | 2026-04-16 | 25,000 | $40.31 | $1.01M | 1,441,934 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-15 | 2026-04-16 | 25,000 | $40.14 | $1.00M | 1,466,934 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-14 | 2026-04-16 | 3,300 | $40.00 | $132.0K | 1,491,934 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-13 | 2026-04-14 | 32,744 | $38.37 | $1.26M | 1,137,599 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-04-10 | 2026-04-14 | 14,333 | — | $0 | 157,662 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-04-10 | 2026-04-14 | 13,834 | — | $0 | 96,835 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-04-10 | 2026-04-14 | 13,834 | — | $0 | 1,156,010 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-10 | 2026-04-14 | 21,433 | $40.12 | $859.9K | 1,495,234 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-04-10 | 2026-04-14 | 14,333 | — | $0 | 1,170,343 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-04-09 | 2026-04-13 | 25,000 | $40.12 | $1.00M | 1,516,667 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2026-01-16 | 2026-01-21 | 173,016 | — | $0 | 173,016 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2026-01-16 | 2026-01-21 | 115,344 | — | $0 | 1,152,872 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2026-01-12 | 2026-01-13 | 66,610 | $37.43 | $2.49M | 1,037,528 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-01-09 | 2026-01-13 | 57,332 | — | $0 | 171,995 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2026-01-09 | 2026-01-13 | 13,833 | — | $0 | 110,669 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-01-09 | 2026-01-13 | 13,833 | — | $0 | 1,046,806 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2026-01-09 | 2026-01-13 | 57,332 | — | $0 | 1,104,138 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-10-13 | 2025-10-15 | 20,261 | $23.41 | $474.3K | 1,032,973 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2025-10-10 | 2025-10-15 | 13,834 | — | $0 | 124,502 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2025-10-10 | 2025-10-15 | 13,834 | — | $0 | 1,053,234 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-02 | 2025-09-02 | 13,464 | $123.68 | $1.67M | 57,510 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-08-29 | 2025-08-29 | 20,000 | $121.27 | $2.43M | 70,974 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-08-28 | 2025-08-29 | 20,000 | $121.60 | $2.43M | 90,974 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-08-27 | 2025-08-29 | 20,000 | $122.30 | $2.45M | 110,974 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-08-26 | 2025-08-26 | 20,000 | $120.03 | $2.40M | 130,974 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-08-22 | 2025-08-26 | 16,694 | $120.08 | $2.00M | 150,974 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-07-14 | 2025-07-15 | 20,252 | $14.28 | $289.2K | 1,038,560 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-07-14 | 2025-07-15 | 20,252 | $14.28 | $289.2K | 1,038,560 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2025-07-11 | 2025-07-15 | 13,833 | — | $0 | 138,336 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2025-07-11 | 2025-07-15 | 13,833 | — | $0 | 138,336 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2025-07-11 | 2025-07-15 | 13,833 | — | $0 | 1,058,812 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2025-07-11 | 2025-07-15 | 13,833 | — | $0 | 1,058,812 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 1,429 | — | $0 | 1,429 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 3,166 | — | $0 | 3,166 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-06-04 | 2025-06-05 | 30,610 | $16.97 | $519.5K | 1,044,979 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2025-06-03 | 2025-06-05 | 69,169 | — | $0 | 152,169 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2025-06-03 | 2025-06-05 | 69,169 | — | $0 | 1,075,589 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-04-14 | 2025-04-16 | 14,130 | $13.57 | $191.7K | 1,006,420 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 1,408 | — | $0 | 1,408 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2025-01-14 | 2025-01-14 | 22,343 | $11.78 | $263.2K | 1,019,177 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2025-01-11 | 2025-01-14 | 229,327 | — | $0 | 229,327 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2025-01-11 | 2025-01-14 | 229,327 | — | $0 | 1,041,520 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2024-10-14 | 2024-10-15 | 8,053 | $11.11 | $89.5K | 812,193 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2024-07-12 | 2024-07-15 | 8,053 | $12.53 | $100.9K | 818,932 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 5,799 | — | $0 | 5,799 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2024-04-12 | 2024-04-16 | 8,360 | $14.58 | $121.9K | 826,985 | SEC↗ |
| LQDA Liquidia Corp | S Sale | 2024-03-18 | 2024-03-19 | 28,583 | $15.82 | $452.2K | 835,345 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-03-15 | 2024-03-15 | 2,347 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-03-15 | 2024-03-15 | 2,347 | $29.91 | $70.2K | 123,103 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-03-15 | 2024-03-15 | 2,347 | $71.61 | $168.1K | 120,756 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-03-14 | 2024-03-15 | 16,976 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-03-14 | 2024-03-15 | 13,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-03-14 | 2024-03-15 | 16,976 | $25.53 | $433.4K | 137,732 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-03-14 | 2024-03-15 | 13,000 | $22.03 | $286.4K | 133,756 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 16,976 | $69.70 | $1.18M | 120,756 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-03-14 | 2024-03-15 | 13,000 | $69.70 | $906.1K | 120,756 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 1,425 | — | $0 | 1,425 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2024-01-11 | 2024-01-16 | 221,338 | — | $0 | 221,338 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2024-01-11 | 2024-01-16 | 221,338 | — | $0 | 862,143 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2023-12-14 | 2023-12-18 | 139,665 | $7.16 | $1.00M | 640,805 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 5,681 | — | $0 | 5,681 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 2,082 | — | $0 | 2,082 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2023-01-11 | 2023-01-13 | 371,154 | — | $0 | 371,154 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2023-01-11 | 2023-01-13 | 289,500 | — | $0 | 496,749 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,807 | — | $0 | 0 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2023-01-03 | 2023-01-05 | 15,807 | — | $0 | 207,249 | SEC↗ |
| LQDA Liquidia Corp | M Exercise deriv | 2022-10-03 | 2022-10-04 | 47,423 | — | $0 | 15,807 | SEC↗ |
| LQDA Liquidia Corp | M Exercise | 2022-10-03 | 2022-10-04 | 47,423 | — | $0 | 207,250 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-09-06 | 2022-09-07 | 43,820 | $5.57 | $244.1K | 159,827 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2022-08-31 | 2023-04-10 | 993 | $4.90 | $4.9K | 116,007 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-08-31 | 2022-09-01 | 993 | $4.90 | $4.9K | 116,007 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2022-06-17 | 2022-06-22 | 931,475 | — | $0 | 931,475 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 16,976 | — | $0 | 16,976 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2022-05-24 | 2022-05-25 | 28,000 | $3.53 | $98.8K | 46,595 | SEC↗ |
| LQDA Liquidia Corp | A Award | 2022-03-31 | 2022-04-20 | 154,167 | — | $0 | 1,541,667 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 2,347 | — | $0 | 2,347 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2022-01-03 | 2022-01-04 | 1,682,827 | — | $0 | 1,763,180 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2022-01-03 | 2022-01-04 | 63,230 | — | $0 | 63,230 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-19 | 2021-11-23 | 3,950 | $37.30 | $147.3K | 120,756 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-08-20 | 2021-09-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-06-24 | 2021-06-28 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 7,325 | — | $0 | 7,325 | SEC↗ |
| LQDA Liquidia Corp | P Buy | 2021-04-13 | 2021-04-15 | 99,206 | $2.52 | $250.0K | 111,706 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2021-03-24 | 2021-03-26 | 30,353 | — | $0 | 30,353 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 1,463 | — | $0 | 1,463 | SEC↗ |
| LQDA Liquidia Corp | A Award deriv | 2020-11-18 | 2020-11-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LQDA Liquidia Corp | J Other | 2020-11-18 | 2020-11-19 | 1,387,500 | $6.00 | $8.32M | 1,387,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-06-19 | 2020-06-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 4,496 | — | $0 | 4,496 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-14 | 9,127 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-14 | 11,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-14 | 5,193 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-14 | 34,866 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2020-01-10 | 2020-01-14 | 5,193 | $8.02 | $41.6K | 70,940 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2020-01-10 | 2020-01-14 | 11,000 | $4.95 | $54.5K | 81,940 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2020-01-10 | 2020-01-14 | 34,866 | $12.95 | $451.5K | 116,806 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2020-01-10 | 2020-01-14 | 9,127 | $9.00 | $82.1K | 65,747 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer deriv | 2019-11-12 | 2019-11-12 | 10,000 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer deriv | 2019-11-12 | 2019-11-12 | 33,000 | — | $0 | 0 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | D To issuer | 2019-11-12 | 2019-11-12 | 66,993 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2019-07-03 | 2019-07-05 | 13,000 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2019-07-03 | 2019-07-05 | 3,672 | — | $0 | 7,344 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2019-07-03 | 2019-07-05 | 39,948 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2019-07-03 | 2019-07-05 | 39,948 | $2.85 | $113.9K | 43,620 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2019-07-03 | 2019-07-05 | 13,000 | $3.45 | $44.9K | 56,620 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2019-07-03 | 2019-07-05 | 3,672 | $3.67 | $13.5K | 3,672 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | S Sale | 2019-07-01 | 2019-07-02 | 1,308 | $14.17 | $18.5K | 66,993 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-06-21 | 2019-06-25 | 5,500 | — | $0 | 5,500 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 13,000 | — | $0 | 13,000 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award deriv | 2019-04-26 | 2019-04-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 255,000 | — | $0 | 255,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-03-19 | 2019-03-21 | 34,866 | — | $0 | 34,866 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | A Award | 2019-02-05 | 2019-02-07 | 6,901 | — | $0 | 68,301 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2018-12-20 | 2018-12-21 | 1,169 | $6.25 | $7.3K | 61,400 | SEC↗ |
| DOVA Dova Pharmaceuticals Inc. | P Buy | 2018-12-19 | 2018-12-21 | 28,831 | $6.22 | $179.3K | 60,231 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | P Buy | 2018-09-07 | 2018-09-07 | 7,408 | $13.56 | $100.5K | 9,908 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-15 | 2018-06-18 | 5,500 | — | $0 | 5,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-06-11 | 2018-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2018-06-11 | 2018-06-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 6,500 | — | $0 | 6,500 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-04-05 | 39,948 | — | $0 | 39,948 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-02-13 | 2018-02-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2017-09-27 | 2017-09-29 | 4,500 | — | $0 | 4,500 | SEC↗ |
| DOVA Dova Pharmaceuticals, Inc. | P Buy | 2017-07-05 | 2017-07-07 | 31,400 | $17.00 | $533.8K | 31,400 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2017-06-27 | 2017-06-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2017-03-29 | 2017-03-30 | 35,194 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2017-03-29 | 2017-03-30 | 7,344 | — | $0 | 3,672 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2017-03-29 | 2017-03-30 | 7,344 | $3.67 | $27.0K | 11,718 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2017-03-29 | 2017-03-30 | 35,194 | $4.95 | $174.2K | 46,912 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 35,194 | — | $0 | 35,194 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2016-05-27 | 2016-06-01 | 5,193 | — | $0 | 5,193 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | A Award deriv | 2016-03-15 | 2016-03-15 | 245,000 | — | $0 | 245,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-02-12 | 2016-02-17 | 9,000 | — | $0 | 0 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-02-12 | 2016-02-17 | 9,000 | $65.80 | $592.2K | 9,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-02-12 | 2016-02-17 | 9,000 | $126.56 | $1.14M | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-27 | 2016-01-28 | 3,000 | — | $0 | 9,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-27 | 2016-01-28 | 3,000 | $65.80 | $197.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-27 | 2016-01-28 | 3,000 | $125.36 | $376.1K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-22 | 2016-01-26 | 3,000 | — | $0 | 12,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-22 | 2016-01-26 | 3,000 | $129.44 | $388.3K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-22 | 2016-01-26 | 3,000 | $65.80 | $197.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-20 | 2016-01-21 | 3,000 | — | $0 | 15,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-20 | 2016-01-21 | 3,000 | $128.61 | $385.8K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-20 | 2016-01-21 | 3,000 | $65.80 | $197.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-15 | 2016-01-20 | 3,000 | — | $0 | 18,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-15 | 2016-01-20 | 3,000 | $133.10 | $399.3K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-15 | 2016-01-20 | 3,000 | $65.80 | $197.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-13 | 2016-01-14 | 3,000 | — | $0 | 21,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-13 | 2016-01-14 | 3,000 | $135.82 | $407.5K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-13 | 2016-01-14 | 3,000 | $65.80 | $197.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-08 | 2016-01-11 | 4,000 | — | $0 | 24,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-08 | 2016-01-11 | 4,000 | $141.50 | $566.0K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-08 | 2016-01-11 | 4,000 | $65.80 | $263.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-06 | 2016-01-07 | 4,000 | — | $0 | 28,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-06 | 2016-01-07 | 4,000 | $65.80 | $263.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-06 | 2016-01-07 | 4,000 | $147.12 | $588.5K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2016-01-04 | 2016-01-05 | 5,000 | — | $0 | 32,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2016-01-04 | 2016-01-05 | 5,000 | $155.54 | $777.7K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2016-01-04 | 2016-01-05 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-30 | 2015-12-31 | 5,000 | — | $0 | 37,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-30 | 2015-12-31 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-30 | 2015-12-31 | 5,000 | $158.53 | $792.6K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-28 | 2015-12-30 | 5,000 | — | $0 | 42,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-28 | 2015-12-30 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-28 | 2015-12-30 | 5,000 | $160.86 | $804.3K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-23 | 2015-12-28 | 5,000 | — | $0 | 47,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-23 | 2015-12-28 | 5,000 | $159.90 | $799.5K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-23 | 2015-12-28 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-18 | 2015-12-21 | 5,000 | — | $0 | 52,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-18 | 2015-12-21 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-18 | 2015-12-21 | 5,000 | $155.18 | $775.9K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-16 | 2015-12-17 | 5,000 | — | $0 | 57,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-16 | 2015-12-17 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-16 | 2015-12-17 | 5,000 | $159.45 | $797.3K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-11 | 2015-12-14 | 4,000 | — | $0 | 62,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-11 | 2015-12-14 | 4,000 | $153.16 | $612.6K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-11 | 2015-12-14 | 4,000 | $65.80 | $263.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-09 | 2015-12-10 | 4,000 | — | $0 | 66,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-09 | 2015-12-10 | 4,000 | $153.68 | $614.7K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-09 | 2015-12-10 | 4,000 | $65.80 | $263.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-04 | 2015-12-08 | 5,000 | — | $0 | 70,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-04 | 2015-12-08 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-04 | 2015-12-08 | 5,000 | $158.80 | $794.0K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-12-02 | 2015-12-03 | 5,000 | — | $0 | 75,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-12-02 | 2015-12-03 | 5,000 | $65.80 | $329.0K | 5,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-12-02 | 2015-12-03 | 5,000 | $156.76 | $783.8K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-27 | 2015-11-30 | 4,000 | — | $0 | 80,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-27 | 2015-11-30 | 4,000 | $65.80 | $263.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-27 | 2015-11-30 | 4,000 | $154.26 | $617.0K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-25 | 2015-11-30 | 3,500 | — | $0 | 84,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-25 | 2015-11-30 | 1,500 | — | $0 | 80,500 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-25 | 2015-11-30 | 3,500 | $155.51 | $544.3K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-25 | 2015-11-30 | 1,500 | $61.06 | $91.6K | 2,059 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-25 | 2015-11-30 | 3,500 | $65.80 | $230.3K | 4,059 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-25 | 2015-11-30 | 1,500 | $155.51 | $233.3K | 559 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 4,374 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 4,374 | $5.94 | $26.0K | 4,374 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-20 | 2015-11-24 | 4,000 | — | $0 | 82,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-20 | 2015-11-24 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-20 | 2015-11-24 | 4,000 | $151.17 | $604.7K | 559 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-19 | 2015-11-23 | 9,127 | — | $0 | 9,127 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-18 | 2015-11-20 | 4,000 | — | $0 | 86,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-18 | 2015-11-20 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-18 | 2015-11-20 | 4,000 | $151.55 | $606.2K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-13 | 2015-11-17 | 4,000 | — | $0 | 90,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-13 | 2015-11-17 | 4,000 | $146.79 | $587.2K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-13 | 2015-11-17 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-11 | 2015-11-12 | 4,000 | — | $0 | 94,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-11 | 2015-11-12 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-11 | 2015-11-12 | 4,000 | $148.66 | $594.6K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-06 | 2015-11-09 | 4,000 | — | $0 | 98,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-06 | 2015-11-09 | 4,000 | $153.62 | $614.5K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-06 | 2015-11-09 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-11-04 | 2015-11-06 | 4,000 | — | $0 | 102,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-11-04 | 2015-11-06 | 4,000 | $151.00 | $604.0K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-11-04 | 2015-11-06 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-30 | 2015-11-02 | 4,000 | — | $0 | 106,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-30 | 2015-11-02 | 4,000 | $146.63 | $586.5K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-30 | 2015-11-02 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-28 | 2015-10-30 | 12,000 | — | $0 | 110,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-28 | 2015-10-30 | 12,000 | $61.06 | $732.7K | 12,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-28 | 2015-10-30 | 12,000 | $137.15 | $1.65M | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-27 | 2015-10-28 | 2,500 | — | $0 | 0 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-27 | 2015-10-28 | 2,500 | $57.15 | $142.9K | 3,059 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-27 | 2015-10-28 | 2,500 | $137.10 | $342.8K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-23 | 2015-10-26 | 3,000 | — | $0 | 122,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-23 | 2015-10-26 | 3,000 | $61.06 | $183.2K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-23 | 2015-10-26 | 3,000 | $126.04 | $378.1K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-16 | 2015-10-19 | 6,000 | — | $0 | 125,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-16 | 2015-10-19 | 6,000 | $61.06 | $366.4K | 6,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-16 | 2015-10-19 | 6,000 | $128.60 | $771.6K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-06 | 2015-10-07 | 3,000 | — | $0 | 2,500 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-06 | 2015-10-07 | 3,000 | $57.15 | $171.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-06 | 2015-10-07 | 3,000 | $125.28 | $375.8K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-10-02 | 2015-10-05 | 3,000 | — | $0 | 131,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-10-02 | 2015-10-05 | 3,000 | $61.06 | $183.2K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-10-02 | 2015-10-05 | 3,000 | $130.90 | $392.7K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-30 | 2015-10-01 | 3,000 | — | $0 | 134,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-30 | 2015-10-01 | 3,000 | $131.24 | $393.7K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-30 | 2015-10-01 | 3,000 | $61.06 | $183.2K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-29 | 2015-09-30 | 3,000 | — | $0 | 5,500 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-29 | 2015-09-30 | 3,000 | $136.97 | $410.9K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-29 | 2015-09-30 | 3,000 | $57.15 | $171.4K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-25 | 2015-09-28 | 3,000 | — | $0 | 137,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-25 | 2015-09-28 | 3,000 | $137.39 | $412.2K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-25 | 2015-09-28 | 3,000 | $61.06 | $183.2K | 3,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-23 | 2015-09-24 | 4,000 | — | $0 | 140,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-23 | 2015-09-24 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-23 | 2015-09-24 | 4,000 | $141.98 | $567.9K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-22 | 2015-09-23 | 4,000 | — | $0 | 8,500 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-22 | 2015-09-23 | 4,000 | $144.82 | $579.3K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-22 | 2015-09-23 | 4,000 | $57.15 | $228.6K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-18 | 2015-09-21 | 4,000 | — | $0 | 144,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-18 | 2015-09-21 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-18 | 2015-09-21 | 4,000 | $150.71 | $602.8K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-16 | 2015-09-17 | 4,000 | — | $0 | 148,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-16 | 2015-09-17 | 4,000 | $61.06 | $244.2K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-16 | 2015-09-17 | 4,000 | $152.22 | $608.9K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-15 | 2015-09-17 | 4,000 | — | $0 | 12,500 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-15 | 2015-09-17 | 4,000 | $57.15 | $228.6K | 4,559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | D To issuer | 2015-09-15 | 2015-09-17 | 4,000 | $154.91 | $619.6K | 559 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise deriv | 2015-09-11 | 2015-09-14 | 5,000 | — | $0 | 152,000 | SEC↗ |
| UTHR UNITED THERAPEUTICS Corp | M Exercise | 2015-09-11 | 2015-09-14 | 5,000 | $61.06 | $305.3K | 5,559 | SEC↗ |